ClinicalTrials.gg
RecruitingNCT07438938Lazarus-AOIUpdated Feb 27, 2026

Measurement of Airway Opening Index During Out-of-hospital Cardiac Arrest: The Lazarus AOI Trial.

An observational study in Cardiac Arrest (CA), Out-of-hospital Cardiac Arrest (OHCA) and Resuscitated Sudden Cardiac Death, sponsored by University Hospital, Ghent. Recruiting at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-27.

Primary conditionOut-of-Hospital Cardiac ArrestRegistry: Heart ArrestReclassifiedWhy we changed it
Registry
Heart Arrest — the first condition term the registry derived for this study.
ClinicalTrials.gg
Out-of-Hospital Cardiac Arrest
Why
  1. The study's listed conditions name Out-of-Hospital Cardiac Arrest, a narrower term within Heart Arrest.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University Hospital, Ghent · Observational

How we know

From the registry’s dates

  • Started Oct 2022; still recruiting 4 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
150
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Out-of-Hospital Cardiac Arrest with a site in Belgium — 4 open to participants now, 5 under way, 1 of them phase 3. Out-of-Hospital Cardiac Arrest · Belgium.

Started
2022
the only one that year
Observational
4 of 13
2 open now
Registered
12th of 13
by date
Lead sponsor
3 of 13
University Hospital, Ghent

Among the 13 studies in Out-of-Hospital Cardiac Arrest with a site in Belgium, this one is the only one that started in 2022, is one of 4 observational ones, and was the 12th registered.

Out-of-Hospital Cardiac Arrest

314 studies on the registry are indexed under Out-of-Hospital Cardiac Arrest; 93 are open to participants now.

Browse Out-of-Hospital Cardiac Arrest studies →

Open to participants now

4 of the 13 studies in Out-of-Hospital Cardiac Arrest with a site in Belgium are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →

Who these studies take

Of the 66 Out-of-Hospital Cardiac Arrest studies recruiting now, 46 (70%) set no upper age limit and 13 (20%) stop at 75 or younger; 8 take children under 18; 7 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Out-of-Hospital Cardiac Arrest with a site in Belgium, or all of them as a file.
02

Study summary

Out-of-hospital cardiac arrest (OHCA) is a leading cause of death worldwide. Despite constantly improving resuscitation techniques, the chances of survival remain limited. During cardiopulmonary resuscitation (CPR), a closure of the airway may occur, impeding ventilation. This phenomenon also complicates the interpretation of the end-tidal CO2 (ETCO2) in the capnogram. The extent to which airway closure occurs is quantified by the Airway Opening Index (AOI). This can be calculated from the capnogram and is seen as a measure of the quality of CPR applied as well as a possible indicator to predict the outcome of CPR.

In this study, we analyse capnogram data from approximately 150 cases, collected during interventions for OHCA and logged in the Lazarus database (UZ Gent and AZORG) to answer three research questions below:

  1. What is the prevalence of AOI during CPR?
  2. Is there a correlation between AOI and return of spontaneous circulation (ROSC)?
  3. Does the application of positive end-expiratory pressure (PEEP) affect the AOI and ROSC?

A mathematical model for calculating AOI, based on a method from previous work by Bandhari et al. [1] will be developed. Using this model, the AOI will be calculated from the individual capnograms for all cases in the Lazarus database.

In addition, a multivariable regression model will be used to analyse whether AOI can be used to predict ROSC. Corrections will be made for relevant confounders such as age, gender, witnessed arrest and rhythm pattern.

Finally, it is investigated whether PEEP has a positive influence on AOI. This study aims to contribute to better insights into airway dynamics during CPR and the optimization of ventilation in OHCA.

Read the detailed description

This study is a retrospective observational cohort study based on capnography data from out-of-hospital cardiac arrest cases registered in the Lazarus database.

03

Conditions studied

  • Cardiac Arrest (CA)
  • Out-of-hospital Cardiac Arrest (OHCA)
  • Resuscitated Sudden Cardiac Death

Browse trials for

Keywords

  • capnography
  • airway closure
04

In context

Out-of-Hospital Cardiac Arrest Reclassified

314 studies on the registry are indexed under Out-of-Hospital Cardiac Arrest; 93 are open to participants now.

This study's planned enrollment of 150 is below the median of 300 across 128 observational studies indexed under Out-of-Hospital Cardiac Arrest.

Browse Out-of-Hospital Cardiac Arrest studies →

Lead sponsor

University Hospital, Ghent is the lead sponsor of 689 studies on the registry; 157 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.

Compared within Out-of-Hospital Cardiac Arrest, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Heart Arrest. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

This retrospective observational cohort study included adult patients who suffered an out-of-hospital cardiac arrest (OHCA) and were treated by the Mobile Emergency Team (MET) of Ghent University Hospital. All cases were registered in the Lazarus database, which prospectively collects prehospital CPR data including continuous capnography recordings.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult (over 18 years old) patients with out-of-hospital cardiac arrest.
  • Patients undergoing cardiopulmonary resuscitation (CPR).
  • Patients who were intubated and had available capnogram recordings immediately after intubation.

Exclusion criteria

Exclusion Criteria:

  • Patients that were not intubated
  • Patients that did not receive CPR following intubation
  • Cases with a technical challenge with the ETCO₂ measurement (i.e., issues with waveform data of the capnogram.
06

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • ROSC

    Patients with return-of-spontaneous circulation during initial resuscitation.

  • non-ROSC

    Patients without return-of-spontaneous circulation during initial resuscitation.

07

What researchers measure

Primary outcomes

  1. ROSC

    Return-of-spontaneous circulation during initial resuscitation.

    Time frame: Initial resuscitation (first day)

08

Study locations

1 of 1 sites recruiting
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2022 (actual). Primary completion is estimated for Sep 2026, 47 months after the start.

Of 69 non-industry observational studies under Out-of-Hospital Cardiac Arrest, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 75. This study's planned 47 months is close to that.

Counting every sponsor, half of 69 studies reached it within 46 months; a quarter within 20 and three quarters within 75.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2025
First posted
Feb 27, 2026
StartActual
Oct 1, 2022
Primary completionEst.
Sep 30, 2026
CompletionEst.
Jan 1, 2027
Last update
Feb 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT07438938
Responsible party
Sponsor
First posted
Feb 27, 2026
Start date
Oct 1, 2022
Primary completion
Sep 30, 2026 (estimated)
Completion
Jan 1, 2027 (estimated)
Last update
Feb 27, 2026

Study contacts

Said Hachimi Idrissi, MD, PhD
Contact
SAID.HACHIMIIDRISSI@ugent.be
0032 9 332 50 24
Thomas Tackaert, MD
Contact
thomas.tackaert@ugent.be

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion